Metformin Hydrochloride Lyrus Life Sciences

Metformin Hydrochloride, the active ingredient in Metformin Hydrochloride Lyrus Life Sciences, is a biguanide presented as an oral dosage form for oral use. It is used to treat type 2 diabetes mellitus in adult patients and helps control blood sugar levels by decreasing hepatic glucose output and improving peripheral insulin sensitivity.

GNH USA supplies Metformin Hydrochloride Lyrus Life Sciences as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies, and clinics worldwide, providing reliable bulk quantities under strict quality standards.

Metformin Hydrochloride is a biguanide antidiabetic that improves glycemic control in several glucose‑related conditions.

Type 2 diabetes mellitus: lowers fasting and post‑prandial blood glucose levels. Prediabetes (impaired glucose tolerance): delays progression to overt diabetes when used with lifestyle measures. Polycystic ovary syndrome: improves insulin resistance and may help regulate menstrual cycles (off‑label use).

Metformin Hydrochloride may cause a range of adverse reactions, from mild gastrointestinal symptoms to rare but serious conditions.

Common Side Effects: - Gastrointestinal upset: nausea, abdominal discomfort, or flatulence. - Diarrhea: loose stools, often transient. - Metallic taste: altered taste perception. - Loss of appetite: reduced desire to eat.

Serious or Rare Side Effects: - Lactic acidosis: accumulation of lactate leading to metabolic acidosis. - Severe skin reactions: such as Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Hepatic dysfunction: elevated liver enzymes or hepatitis.

Metformin Hydrochloride requires careful patient assessment and monitoring. - Renal function assessment: evaluate creatinine clearance before initiating therapy. - Hepatic impairment: use with caution in patients with liver disease. - Contraindication in severe renal disease: avoid if eGFR <30 mL/min/1.73 m². - Monitor for lactic acidosis: watch for unexplained fatigue, myalgia, or respiratory distress. - Use in elderly: start at lower dose and titrate slowly. - Pregnancy and lactation: safety not established; weigh risks and benefits. - Store at room temperature: keep in original container, protect from moisture and direct sunlight.

Metformin Hydrochloride can interact with several medicines, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Iodinated contrast agents: may precipitate acute renal failure and increase lactic acidosis risk. - Cimetidine: can raise metformin plasma levels. - Alcohol: potentiates risk of lactic acidosis.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may mask hypoglycemia symptoms. - Warfarin: metformin may affect INR stability.